Skip to content

Laparoscopic Cholecystectomy or Conservative Treatment in the Acute Cholecystitis of Elderly Patients

Acute Cholecystitis in the Elderly: Comparative Randomized and Cohort Study of Laparoscopic Cholecystectomy vs. Conservative Treatment With Antibiotics Alone

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02972944
Enrollment
200
Registered
2016-11-25
Start date
2016-10-31
Completion date
2021-12-31
Last updated
2021-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystitis, Acute

Brief summary

Cholecystectomy is the only curative treatment for gallstone disease of acute calculous cholecystitis.The purpose of this study is to find the most effective treatment (laparoscopic cholecystectomy vs. conservative) for elderly patients with acute cholecystitis. Therefore a randomized multi-centre study of 200 elderly patients suffering from acute cholecystitis is performed with additional cohort of all elderly patients with acute cholecystitis in the study hospitals during study period.

Detailed description

The increasing age is one of the main risk factors for developing complicated gallstone disease. Currently, there is lack of good quality studies comparing risks and benefits of early laparoscopic cholecystectomy in the elderly patients. Cholecystectomy is the only curative treatment for gallstone disease of acute calculous cholecystitis. Aim: The purpose is to find out the most effective treatment (laparoscopic cholecystectomy vs. conservative) with the least morbidity for elderly patients with acute cholecystitis. Study design: multicenter randomized controlled trial (RCT) and additional cohort of all elderly patients (\>75 years old) with acute cholecystitis. Patient allocation: Elderly patients with diagnosis of acute cholecystitis will be randomly allocated to either early laparoscopic cholecystectomy or treatment with antibiotics. Reasonably healthy elderly patients (ASA 2-3) are included in this study, excluding the patients with ASA-class above 4. Interventions: The study group of patients will undergo early laparoscopic cholecystectomy within 48 hours after hospitalization. The control group will be managed conservatively with intravenous antibiotics and elective cholecystectomy will not be scheduled later. Primary outcome: Assessment of morbidities related to acute cholecystitis and individual quality of life. Secondary outcomes include number of hospital admissions, length of hospitalization, pain, complications, mortality and cost analysis. Sample size and data-analysis: Based on data of previous studies the recruitment of 200 patients in total is expected. Follow-up will be for 12 months. In addition of RCT, we decided to record and analyze all acute cholecystitis of elderly patients in study hospitals during the study period. We will present these results in the connection of RCT analysis.

Interventions

PROCEDURELaparoscopic cholecystectomy

Sponsors

Turku University Hospital
CollaboratorOTHER_GOV
Tampere University Hospital
CollaboratorOTHER
Oulu University Hospital
CollaboratorOTHER
Mikkeli Central Hospital
CollaboratorOTHER
North Karelia Central Hospital
CollaboratorOTHER
Jyväskylä Central Hospital
CollaboratorOTHER
Päijänne Tavastia Central Hospital
CollaboratorOTHER
Central Hospital of Hämeenlinna
CollaboratorUNKNOWN
Central Hospital of Jorvi
CollaboratorUNKNOWN
Kuopio University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Radiologically confirmed acute cholecystitis * Age over 75 yrs * American Association of Anesthesiologists Classification class 2-3 * Duration of symptoms \< 5 days

Exclusion criteria

* American Association of Anesthesiologists Classification class 4-5 * Age under 75 yrs * Peritonitis * Sepsis or septic shock * Duration of symptoms over 6 days * Cholestasis or diagnosed stone at common biliary duct. * Acute Pancreatitis

Design outcomes

Primary

MeasureTime frameDescription
Specific Morbidity Index Scores1 year postoperativelyThe primary outcome is morbidity, all complications will be scored (according to morbidity-index -chart) (ref: Gutt et al: Ann Surg 2013;258:385-393)

Secondary

MeasureTime frameDescription
Pain scores (0-100)pre-operatively, 1 week, 1 month and 1 year postoperativelyPain (VAS, range 0-100)
Number of patients with failure of antibiotic therapy1 week, 1 month and 1 year postoperativelyRecurrent cholecystitis after antibiotic therapy
Time of hospitalization (days)1 monthLength of time at hospital
Quality of life RAND-36 scorespre-operatively and 1 year postoperativelyQuality of life according to RAND-36
Number of patients with complications1 week, 1 month and 1 year postoperativelyBile duct injury, re-operations, bile leakage, hemorragia, wound infections, pneumonia etc.
Cost analysis in euros1 week, 1 month and 1 year postoperativelycost analysis comparison between groups
Mortality (number of patients)1 monthDeath within 30 d

Countries

Finland

Contacts

Primary ContactHannu Paajanen, Professor
Hannu.Paajanen@kuh.fi17 173 311
Backup ContactAntti Kivivuori, MD
Antti.Kivivuori@esshp.fi443516698

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026